Philipp Lachenmann: DELPHI Rationale


Schering Prize 2007

Dr. Kathrin Schneider

"Novel natural products for human health"

Sanofi-Aventis Germany GmbH

Dr. Kathrin Schneider (born in 1979) studied chemistry at the University of Tuebingen until 2004. In November of that year, she began her thesis work under the supervision of Prof. Dr. Roderich Süßmuth at the Department of Chemistry at the Technical University of Berlin. In late 2007, she completed her doctoral thesis on “Structure Elucidation of Proximicins, Furan Analogues of Netropsine from the Marine Actinomycetes Verrucosispora and Studies on the Metabolite Production of the Plant Growth Promoting Bacillus Amyloliquefaciens FZB42.“ Drawing on both classical screening and modern genomic approaches, Kathrin Schneider’s thesis has made a contribution to the structure elucidation and classification of novel natural substances. She currently heads a lab at Sanofi-Aventis Deutschland GmbH.



Hybrid Encounters. Tomás Saraceno and Guests

18.04.2018. Berlin | With Hybrid Encounters, the Hybrid Plattform and the Schering Stiftung have created an...

Live-Debatte: Arm durch Wohnen? Wie Mieten bezahlbar bleiben

16.05.2018, Berlin/Braunschweig | Die Mieten in Deutschland steigen kontinuierlich: Seit 2010 zahlen Bundesbürger im Durchschnitt 30...

DOME – Our Relationship with the Cosmos

25.04.2018, Berlin | The interdisciplinary art project DOME invites you to engage with “cosmic realities” at...